findmyKOL

Jack Dipalma, MD

Enriched profile

Professor Emeritus · University of South Alabama

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Mobile, AL · Southeast · United StatesSpecialtyGastroenterologyFocusConstipation+2
Active KOLfindmyKOL type: EliteLatest publication2016Online presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Jack Dipalma is Professor Emeritus at University of South Alabama. ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 23 Oct 2026

Overview

Updated 23 Oct 2026

Jack A. Di Palma, MD, is Professor Emeritus at University of South Alabama. The public record shows 108 publications with 2,214 citations (h-index 29), centered on Constipation, IBD (Crohn's / UC), IBS / Functional GI. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 15 companies.

  • Top research focus: Constipation
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 15 companies

Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
IBD (Crohn's / UC)1 trialIBS / Functional GI1 trialConstipation1 trial

Research focus

OpenAlex concept fingerprint
ConstipationIBD (Crohn's / UC)IBS / Functional GI

Drugs & molecules

across trials, industry payments and publications
GOLYTELYClinical trials—Industry payments60Publications—Rinvoqgeneric · UpadacitinibClinical trials—Industry payments6Publications—Skyrizigeneric · RisankizumabClinical trials—Industry payments6Publications—Zeposiageneric · OzanimodClinical trials—Industry payments4Publications—Creongeneric · Amylase / lipase / proteaseClinical trials—Industry payments3Publications—Entyviogeneric · VedolizumabClinical trials—Industry payments3Publications—Omvohgeneric · MirikizumabClinical trials—Industry payments3Publications—Xeljanzgeneric · TofacitinibClinical trials—Industry payments3Publications—Dupixentgeneric · DupilumabClinical trials—Industry payments2Publications—Gattexgeneric · TeduglutideClinical trials—Industry payments2Publications—Linzessgeneric · LinaclotideClinical trials—Industry payments2Publications—Nerlynxgeneric · NeratinibClinical trials—Industry payments2Publications—

Works with

trial sponsors and companies reporting payments
Braintree Laboratories, Inc.Clinical trials—Industry payments61Abbvie Inc.Clinical trials—Industry payments10Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments5Celgene CorporationClinical trials—Industry payments4Janssen Biotech, Inc.Clinical trials—Industry payments3Lilly USA, LLCClinical trials—Industry payments3Pfizer Inc.Clinical trials—Industry payments3Erbe USA IncClinical trials—Industry payments2Puma Biotechnology, Inc.Clinical trials—Industry payments2Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments2Salix Pharmaceuticals, a division of Bausch Health US, LLCClinical trials—Industry payments2University of South AlabamaClinical trials2Industry payments—Intercept Pharmaceuticals, Inc.Clinical trials—Industry payments1Mahana Therapeutics, Inc.Clinical trials—Industry payments1Mallinckrodt Hospital Products Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
29h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
15companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 23 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 23 Oct 2026

15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 26 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2019)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    100%
    Guanylate Cyclase-C Agonist100%
    Linzess100%
    Part D<11 patients
Where care is delivered (Part B)52.8% facility · 47.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 0 publications: search, sort and filter.Explore →

Online presence

Updated 23 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    usahealthsystem.com/news/new-colonoscopy-prep-tablet

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →usahealthsystem.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 23 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • B.A.

    Adelphi University, Garden City, New York

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →southalabama.edu ↗
  • Medical degree

    New York Medical College, Valhalla, New York

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →southalabama.edu ↗

Editorial & leadership roles

journal and society appointments
  • Fellow

    American Board of Internal Medicine, Gastroenterology (board certification, not a society role)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →southalabama.edu ↗

Awards & honors

honors on the public record
  • Fellow

    American College of Gastroenterology (FACG)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →gi.org ↗

Media & interviews

press, podcasts and appearances
  • Featured speaker

    ACG patient video "Colonoscopy Bowel Prep Myths and Realities"

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →gi.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.